Trial · NCT02060903
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
NCT02060903, Phase 3, Completed, Dr. Reddy's Laboratories Limited, India; results first posted 2020-09-23
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation. Trials, record NCT02060903. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02060903
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
- NCT number
- NCT02060903
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 379 participants, actual
- Lead sponsor
- Dr. Reddy's Laboratories Limited, India
- Conditions
- Head Lice Infestation
- Interventions
- Abametapir Lotion 0.74% w/w, Vehicle Lotion
- First posted
- 2014-02-12
- Last updated
- 2020-09-23
- Results first posted
- 2020-09-23
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of Index Subjects Who Are Lice-free at All Follow-up Visits Through to the Day 14 Visit. | 14 days | Proportion of index subjects randomized into the study who are lice free at all follow up visits through to the Day 14 visit. The index subject of a household was the youngest person within that household with at least 3 live lice present, as assessed over a period of up to 15 minutes at the Screening Visit. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Proportion of Index Subjects Who Are Lice-free at All Follow-up Visits Through to the Day 14 Visit. | 14 days | The ITT population consisted of all 108 index subjects who were enrolled and randomized in the study. | participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Index Subjects Who Are Lice-free at All Follow-up Visits Through to the Day 14 Visit. | Abametapir Lotion 0.74% w/w | 43 | participants | ||
| Proportion of Index Subjects Who Are Lice-free at All Follow-up Visits Through to the Day 14 Visit. | Vehicle Lotion | 28 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Abametapir Lotion 0.74% w/w | 187 | |
| Overall Study | STARTED | Vehicle Lotion | 192 | |
| Overall Study | COMPLETED | Abametapir Lotion 0.74% w/w | 183 | |
| Overall Study | COMPLETED | Vehicle Lotion | 185 | |
| Overall Study | NOT COMPLETED | Abametapir Lotion 0.74% w/w | 4 | |
| Overall Study | NOT COMPLETED | Vehicle Lotion | 7 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Renal Impairment | Renal and urinary disorders | Abametapir Lotion 0.74% w/w | 0 | 186 | 0 |
| serious | Renal Impairment | Renal and urinary disorders | Vehicle Lotion | 1 | 188 | 1 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Abametapir Lotion 0.74% w/w | 0 | 186 |
| Total, all-cause mortality | Vehicle Lotion | 0 | 188 |
| Total, other adverse events | Abametapir Lotion 0.74% w/w | 0 | 186 |
| Total, other adverse events | Vehicle Lotion | 0 | 188 |
| Total, serious adverse events | Abametapir Lotion 0.74% w/w | 0 | 186 |
| Total, serious adverse events | Vehicle Lotion | 1 | 188 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Abametapir Lotion 0.74% w/w vs Vehicle Lotion: Proportion of Index Subjects Who Are Lice-free at All Follow-up Visits Through to the Day 14 Visit. | Trial comparisons |
| Abametapir Lotion 0.74% w/w vs Vehicle Lotion: deaths from any cause | Trial comparisons |
| Abametapir Lotion 0.74% w/w vs Vehicle Lotion: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02060903
GET https://conductscience.org/api/trials/v1/NCT02060903/registered